 | • レポートコード：C-GIR20G2761 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「ホルモン抵抗性乳がんの世界市場2019年」は、グローバルにおけるホルモン抵抗性乳がん市場を展望するレポートです。ホルモン抵抗性乳がんのグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・ホルモン抵抗性乳がんの市場概観 ・ホルモン抵抗性乳がんの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ホルモン抵抗性乳がんの企業別販売動向、市場シェア、市場集中度、競争動向 ・ホルモン抵抗性乳がんの世界市場規模 ・ホルモン抵抗性乳がんの北米市場分析（アメリカ、カナダ、メキシコ等） ・ホルモン抵抗性乳がんのアメリカ市場規模推移 ・ホルモン抵抗性乳がんのカナダ市場規模推移 ・ホルモン抵抗性乳がんのメキシコ市場規模推移 ・ホルモン抵抗性乳がんのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ホルモン抵抗性乳がんのドイツ市場規模推移 ・ホルモン抵抗性乳がんのイギリス市場規模推移 ・ホルモン抵抗性乳がんのロシア市場規模推移 ・ホルモン抵抗性乳がんのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ホルモン抵抗性乳がんの日本市場規模推移 ・ホルモン抵抗性乳がんの中国市場規模推移 ・ホルモン抵抗性乳がんの韓国市場規模推移 ・ホルモン抵抗性乳がんのインド市場規模推移 ・ホルモン抵抗性乳がんの東南アジア市場規模推移 ・ホルモン抵抗性乳がんの南米市場分析（ブラジル、アルゼンチン等） ・ホルモン抵抗性乳がんの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ホルモン抵抗性乳がんの種類別分析/販売量、売上、市場シェア（腫瘍マーカー療法、遺伝子発現療法、遺伝子突然変異療法） ・ホルモン抵抗性乳がんの用途別分析/市場規模（科学研究および生産、生物科学技術、医療技術、医療機器および器具） ・ホルモン抵抗性乳がんの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ホルモン抵抗性乳がんの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Hormone Refractory Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hormone Refractory Breast Cancer.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Hormone Refractory Breast Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hormone Refractory Breast Cancer market by product type and applications/end industries.
Market Segment by Companies, this report covers
AstraZeneca
Boehringer Ingelheim GmbH
Bluefish Pharmaceuticals AB
AmpliMed Corporation
Neopharm
Roche
Sanofi Genzyme
NeoCorp
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tumor Markers Therapy
Gene Expression Therapy
Gene Mutation Therapy
Market Segment by Applications, can be divided into
Scientific Research and Production
Biological Science and Technology
Medical Technology
Medical Apparatus and Instruments
Table of Contents
1 Hormone Refractory Breast Cancer Market Overview
1.1 Product Overview and Scope of Hormone Refractory Breast Cancer
1.2 Classification of Hormone Refractory Breast Cancer by Types
1.2.1 Global Hormone Refractory Breast Cancer Revenue Comparison by Types (2019-2024)
1.2.2 Global Hormone Refractory Breast Cancer Revenue Market Share by Types in 2018
1.2.3 Tumor Markers Therapy
1.2.4 Gene Expression Therapy
1.2.5 Gene Mutation Therapy
1.3 Global Hormone Refractory Breast Cancer Market by Application
1.3.1 Global Hormone Refractory Breast Cancer Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Scientific Research and Production
1.3.3 Biological Science and Technology
1.3.4 Medical Technology
1.3.5 Medical Apparatus and Instruments
1.4 Global Hormone Refractory Breast Cancer Market by Regions
1.4.1 Global Hormone Refractory Breast Cancer Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Hormone Refractory Breast Cancer Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hormone Refractory Breast Cancer Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hormone Refractory Breast Cancer Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Hormone Refractory Breast Cancer Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hormone Refractory Breast Cancer Status and Prospect (2014-2024)
1.5 Global Market Size of Hormone Refractory Breast Cancer (2014-2024)
2 Company Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Hormone Refractory Breast Cancer Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.2 Boehringer Ingelheim GmbH
2.2.1 Business Overview
2.2.2 Hormone Refractory Breast Cancer Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boehringer Ingelheim GmbH Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bluefish Pharmaceuticals AB
2.3.1 Business Overview
2.3.2 Hormone Refractory Breast Cancer Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bluefish Pharmaceuticals AB Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.4 AmpliMed Corporation
2.4.1 Business Overview
2.4.2 Hormone Refractory Breast Cancer Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AmpliMed Corporation Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.5 Neopharm
2.5.1 Business Overview
2.5.2 Hormone Refractory Breast Cancer Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Neopharm Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.6 Roche
2.6.1 Business Overview
2.6.2 Hormone Refractory Breast Cancer Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sanofi Genzyme
2.7.1 Business Overview
2.7.2 Hormone Refractory Breast Cancer Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Genzyme Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.8 NeoCorp
2.8.1 Business Overview
2.8.2 Hormone Refractory Breast Cancer Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 NeoCorp Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
3 Global Hormone Refractory Breast Cancer Market Competition, by Players
3.1 Global Hormone Refractory Breast Cancer Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Hormone Refractory Breast Cancer Players Market Share
3.2.2 Top 10 Hormone Refractory Breast Cancer Players Market Share
3.3 Market Competition Trend
4 Global Hormone Refractory Breast Cancer Market Size by Regions
4.1 Global Hormone Refractory Breast Cancer Revenue and Market Share by Regions
4.2 North America Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
4.3 Europe Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
4.5 South America Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
5 North America Hormone Refractory Breast Cancer Revenue by Countries
5.1 North America Hormone Refractory Breast Cancer Revenue by Countries (2014-2019)
5.2 USA Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
5.3 Canada Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
5.4 Mexico Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
6 Europe Hormone Refractory Breast Cancer Revenue by Countries
6.1 Europe Hormone Refractory Breast Cancer Revenue by Countries (2014-2019)
6.2 Germany Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
6.3 UK Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
6.4 France Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
6.5 Russia Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
6.6 Italy Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Hormone Refractory Breast Cancer Revenue by Countries
7.1 Asia-Pacific Hormone Refractory Breast Cancer Revenue by Countries (2014-2019)
7.2 China Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
7.3 Japan Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
7.4 Korea Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
7.5 India Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
8 South America Hormone Refractory Breast Cancer Revenue by Countries
8.1 South America Hormone Refractory Breast Cancer Revenue by Countries (2014-2019)
8.2 Brazil Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
8.3 Argentina Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
8.4 Colombia Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Hormone Refractory Breast Cancer by Countries
9.1 Middle East and Africa Hormone Refractory Breast Cancer Revenue by Countries (2014-2019)
9.2 Saudi Arabia Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
9.3 UAE Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
9.4 Egypt Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
9.5 Nigeria Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
9.6 South Africa Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
10 Global Hormone Refractory Breast Cancer Market Segment by Type
10.1 Global Hormone Refractory Breast Cancer Revenue and Market Share by Type (2014-2019)
10.2 Global Hormone Refractory Breast Cancer Market Forecast by Type (2019-2024)
10.3 Tumor Markers Therapy Revenue Growth Rate (2014-2024)
10.4 Gene Expression Therapy Revenue Growth Rate (2014-2024)
10.5 Gene Mutation Therapy Revenue Growth Rate (2014-2024)
11 Global Hormone Refractory Breast Cancer Market Segment by Application
11.1 Global Hormone Refractory Breast Cancer Revenue Market Share by Application (2014-2019)
11.2 Hormone Refractory Breast Cancer Market Forecast by Application (2019-2024)
11.3 Scientific Research and Production Revenue Growth (2014-2019)
11.4 Biological Science and Technology Revenue Growth (2014-2019)
11.5 Medical Technology Revenue Growth (2014-2019)
11.6 Medical Apparatus and Instruments Revenue Growth (2014-2019)
12 Global Hormone Refractory Breast Cancer Market Size Forecast (2019-2024)
12.1 Global Hormone Refractory Breast Cancer Market Size Forecast (2019-2024)
12.2 Global Hormone Refractory Breast Cancer Market Forecast by Regions (2019-2024)
12.3 North America Hormone Refractory Breast Cancer Revenue Market Forecast (2019-2024)
12.4 Europe Hormone Refractory Breast Cancer Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Hormone Refractory Breast Cancer Revenue Market Forecast (2019-2024)
12.6 South America Hormone Refractory Breast Cancer Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Hormone Refractory Breast Cancer Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Hormone Refractory Breast Cancer Picture
Table Product Specifications of Hormone Refractory Breast Cancer
Table Global Hormone Refractory Breast Cancer and Revenue (Million USD) Market Split by Product Type
Figure Global Hormone Refractory Breast Cancer Revenue Market Share by Types in 2018
Figure Tumor Markers Therapy Picture
Figure Gene Expression Therapy Picture
Figure Gene Mutation Therapy Picture
Table Global Hormone Refractory Breast Cancer Revenue (Million USD) by Application (2014-2024)
Figure Hormone Refractory Breast Cancer Revenue Market Share by Applications in 2018
Figure Scientific Research and Production Picture
Figure Biological Science and Technology Picture
Figure Medical Technology Picture
Figure Medical Apparatus and Instruments Picture
Table Global Market Hormone Refractory Breast Cancer Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Hormone Refractory Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Hormone Refractory Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Hormone Refractory Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Hormone Refractory Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Hormone Refractory Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Hormone Refractory Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Hormone Refractory Breast Cancer Type and Applications
Table AstraZeneca Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim GmbH Hormone Refractory Breast Cancer Type and Applications
Table Boehringer Ingelheim GmbH Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Bluefish Pharmaceuticals AB Basic Information, Manufacturing Base and Competitors
Table Bluefish Pharmaceuticals AB Hormone Refractory Breast Cancer Type and Applications
Table Bluefish Pharmaceuticals AB Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table AmpliMed Corporation Basic Information, Manufacturing Base and Competitors
Table AmpliMed Corporation Hormone Refractory Breast Cancer Type and Applications
Table AmpliMed Corporation Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Neopharm Basic Information, Manufacturing Base and Competitors
Table Neopharm Hormone Refractory Breast Cancer Type and Applications
Table Neopharm Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Hormone Refractory Breast Cancer Type and Applications
Table Roche Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Genzyme Basic Information, Manufacturing Base and Competitors
Table Sanofi Genzyme Hormone Refractory Breast Cancer Type and Applications
Table Sanofi Genzyme Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table NeoCorp Basic Information, Manufacturing Base and Competitors
Table NeoCorp Hormone Refractory Breast Cancer Type and Applications
Table NeoCorp Hormone Refractory Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Global Hormone Refractory Breast Cancer Revenue (Million USD) by Players (2014-2019)
Table Global Hormone Refractory Breast Cancer Revenue Share by Players (2014-2019)
Figure Global Hormone Refractory Breast Cancer Revenue Share by Players in 2017
Figure Global Hormone Refractory Breast Cancer Revenue Share by Players in 2018
Figure Global Top 5 Players Hormone Refractory Breast Cancer Revenue Market Share in 2018
Figure Global Top 10 Players Hormone Refractory Breast Cancer Revenue Market Share in 2018
Figure Global Hormone Refractory Breast Cancer Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Hormone Refractory Breast Cancer Revenue (Million USD) by Regions (2014-2019)
Table Global Hormone Refractory Breast Cancer Revenue Market Share by Regions (2014-2019)
Figure Global Hormone Refractory Breast Cancer Revenue Market Share by Regions (2014-2019)
Figure Global Hormone Refractory Breast Cancer Revenue Market Share by Regions in 2018
Figure North America Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Europe Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure South America Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Table North America Hormone Refractory Breast Cancer Revenue by Countries (2014-2019)
Table North America Hormone Refractory Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure North America Hormone Refractory Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure North America Hormone Refractory Breast Cancer Revenue Market Share by Countries in 2018
Figure USA Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Canada Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Mexico Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Table Europe Hormone Refractory Breast Cancer Revenue (Million USD) by Countries (2014-2019)
Figure Europe Hormone Refractory Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Europe Hormone Refractory Breast Cancer Revenue Market Share by Countries in 2018
Figure Germany Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure UK Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure France Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Russia Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Italy Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Hormone Refractory Breast Cancer Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Hormone Refractory Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Hormone Refractory Breast Cancer Revenue Market Share by Countries in 2018
Figure China Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Japan Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Korea Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure India Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Table South America Hormone Refractory Breast Cancer Revenue by Countries (2014-2019)
Table South America Hormone Refractory Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure South America Hormone Refractory Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure South America Hormone Refractory Breast Cancer Revenue Market Share by Countries in 2018
Figure Brazil Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Argentina Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Colombia Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Hormone Refractory Breast Cancer Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Hormone Refractory Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Hormone Refractory Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Hormone Refractory Breast Cancer Revenue Market Share by Countries in 2018
Figure Saudi Arabia Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure UAE Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Egypt Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Nigeria Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Figure South Africa Hormone Refractory Breast Cancer Revenue and Growth Rate (2014-2019)
Table Global Hormone Refractory Breast Cancer Revenue (Million USD) by Type (2014-2019)
Table Global Hormone Refractory Breast Cancer Revenue Share by Type (2014-2019)
Figure Global Hormone Refractory Breast Cancer Revenue Share by Type (2014-2019)
Figure Global Hormone Refractory Breast Cancer Revenue Share by Type in 2018
Table Global Hormone Refractory Breast Cancer Revenue Forecast by Type (2019-2024)
Figure Global Hormone Refractory Breast Cancer Market Share Forecast by Type (2019-2024)
Figure Global Tumor Markers Therapy Revenue Growth Rate (2014-2019)
Figure Global Gene Expression Therapy Revenue Growth Rate (2014-2019)
Figure Global Gene Mutation Therapy Revenue Growth Rate (2014-2019)
Table Global Hormone Refractory Breast Cancer Revenue by Application (2014-2019)
Table Global Hormone Refractory Breast Cancer Revenue Share by Application (2014-2019)
Figure Global Hormone Refractory Breast Cancer Revenue Share by Application (2014-2019)
Figure Global Hormone Refractory Breast Cancer Revenue Share by Application in 2018
Table Global Hormone Refractory Breast Cancer Revenue Forecast by Application (2019-2024)
Figure Global Hormone Refractory Breast Cancer Market Share Forecast by Application (2019-2024)
Figure Global Scientific Research and Production Revenue Growth Rate (2014-2019)
Figure Global Biological Science and Technology Revenue Growth Rate (2014-2019)
Figure Global Medical Technology Revenue Growth Rate (2014-2019)
Figure Global Medical Apparatus and Instruments Revenue Growth Rate (2014-2019)
Figure Global Hormone Refractory Breast Cancer Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Hormone Refractory Breast Cancer Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Hormone Refractory Breast Cancer Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Hormone Refractory Breast Cancer Revenue Market Forecast (2019-2024)
Figure Europe Hormone Refractory Breast Cancer Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Hormone Refractory Breast Cancer Revenue Market Forecast (2019-2024)
Figure South America Hormone Refractory Breast Cancer Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Hormone Refractory Breast Cancer Revenue Market Forecast (2019-2024)
ホルモン抵抗性前立腺がん（HRPCA）市場：世界及び中国市場分析・予測（～2024年） Hormone Refractory Prostate Cancer (HRPCA) Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Hormone Refractory Prostate Cancer (HRPCA) industry with a focus on the Chinese market. The report provides key statistics on the marke…- 世界のがんホルモン療法薬市場予測（～2024年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Scope of the Report: The global Cancer Hormon…
- 乳がん検査の世界市場 2019年版：種類別（スクリーニングテスト、診断テスト、モニタリングテスト）、用途別（非浸潤性乳がん、浸潤性乳がん） Scope of the Report: The global Breast Cancer Testing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, als…
- 世界の男性乳癌治療市場予測（～2024年） Male breast cancer (male breast neoplasm) is a rare cancer in males that originates from the breast. Many males with breast cancer have inherited a BRCA mutation, but there are other causes, including alcohol abuse and exposure to certain hormones and ionizing radiation. Scope of the Report: The glo…
- 乳がん診断及び薬物技術の世界市場 2019年版：種類別（マンモグラフィ、生検、その他）、用途別（乳管癌、浸潤性乳管がん、小葉癌、トリプルネガティブ乳がん） Scope of the Report: The global Breast Cancer Diagnostic and Drug Technologies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years,…